Prevalence of Symptoms of Depression and Anxiety in Adults With Cystic Fibrosis Based on the PHQ-9 and GAD-7 Screening Questionnaires

Psychosomatics

Volumn 56, Issue 4, 2015, Pages 345-353

  Quon, Bradley S ^a   Bentham, Wayne D ^b   Unutzer, Jurgen ^b   Chan, Ya Fen ^b   Goss, Christopher H ^b   Aitken, Moira L ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; BODY MASS; DEPRESSION; DIABETES MELLITUS; FEMALE; FORCED EXPIRATORY VOLUME; GENERAL ANXIETY DISORDER 7; GENERAL MENTAL DISEASE ASSESSMENT; HUMAN; INSULIN BLOOD LEVEL; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PATIENT HEALTH QUESTIONNAIRE 9; SUICIDAL IDEATION; ANXIETY DISORDERS; ATTITUDE TO HEALTH; COMORBIDITY; CYSTIC FIBROSIS; DEPRESSIVE DISORDER; PREVALENCE; PSYCHOLOGY; QUESTIONNAIRE; RISK FACTOR; SOCIOECONOMICS; WASHINGTON;

ADULT; ANXIETY DISORDERS; ATTITUDE TO HEALTH; COMORBIDITY; CYSTIC FIBROSIS; DEPRESSIVE DISORDER; HUMANS; MALE; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; WASHINGTON;

EID: 84937519488     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2014.05.017     Document Type: Article

References (22)

1. Meader N., Mitchell A.J., Chew-Graham C., et al. Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies. Br J Gen Pract 2011, 61(593):e808-e820.
2. Latchford G., Duff A.J. Screening for depression in a single CF centre. J Cyst Fibros 2013, 12(6):794-796.
3. Yohannes A.M., Willgoss T.G., Fatoye F.A., Dip M.D., Webb K. Relationship between anxiety, depression, and quality of life in adult patients with cystic fibrosis. Respir Care 2012, 57(4):550-556.
4. Goldbeck L., Besier T., Hinz A., Singer S., Quittner A.L., Group T. Prevalence of symptoms of anxiety and depression in German patients with cystic fibrosis. Chest 2010, 138(4):929-936.
5. Havermans T., Colpaert K., Dupont L.J. Quality of life in patients with cystic fibrosis: association with anxiety and depression. J Cyst Fibros 2008, 7(6):581-584.
6. Riekert K.A., Bartlett S.J., Boyle M.P., Krishnan J.A., Rand C.S. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007, 132(1):231-237.
7. Burke P., Meyer V., Kocoshis S., et al. Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry 1989, 28(6):948-951.
8. Duff A.J., Abbott J., Cowperthwaite C., et al. Depression and anxiety in adolescents and adults with cystic fibrosis in the UK: a cross-sectional study. J Cyst Fibros 2014, 13(6):745-753. doi: 10.1016/j.jcf.2014.02.010. Epub 2014 Mar 15. pii: S1569-1993(14)00050-2.
9. Besier T., Goldbeck L. Growing up with cystic fibrosis: achievement, life satisfaction, and mental health. Qual Life Res 2012, 21(10):1829-1835.
10. Snell C., Fernandes S., Bujoreanu I.S., Garcia G. Depression, illness severity, and healthcare utilization in cystic fibrosis. Pediatr Pulmonol 2014, 49(12):1177-1181. doi: 10.1002/ppul.22990. [Epub 2014 Mar 12].
11. Smith B.A., Modi A.C., Quittner A.L., Wood B.L. Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatr Pulmonol 2010, 45(8):756-763.
12. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16(9):606-613.
13. Spitzer R.L., Kroenke K., Williams J.B., Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006, 166(10):1092-1097.
14. Malpass A., Shaw A., Kessler D., Sharp D. Concordance between PHQ-9 scores and patients' experiences of depression: a mixed methods study. Br J Gen Pract 2010, 60(575):e231-e238.
15. Kertz S., Bigda-Peyton J., Bjorgvinsson T. Validity of the generalized anxiety disorder-7 scale in an acute psychiatric sample. Clin Psychol Psychother 2013, 20(5):456-464.
16. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organization technical report series 1995;854:1-452.
17. Andrade L., Caraveo-Anduaga J.J., Berglund P., et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) surveys. Int J Methods Psychiatr Res 2003, 12(1):3-21.
18. Lowe B., Spitzer R.L., Grafe K., et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 2004, 78(2):131-140.
19. Wittchen H.U., Zhao S., Kessler R.C., Eaton W.W. DSM-III-R generalized anxiety disorder in the National comorbidity survey. Arch Gen Psychiatry 1994, 51(5):355-364.
20. Kroenke K., Spitzer R.L., Williams J.B., Monahan P.O., Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007, 146(5):317-325.
21. Kroenke K., Spitzer R.L., Williams J.B., Lowe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry 2010, 32(4):345-359.
22. 2012 Annual data report to the center directors 2013, Cystic Fibrosis Foundation Patient Registry, Cystic Fibrosis Foundation, Bethesda, MD.